Recombinant specialist Sino Biological starts building first US manufacturing facility
Sino Biological has begun construction of its first US-based manufacturing facility at a 53-acre life science district in Houston.
Sino Biological has begun construction of its first US-based manufacturing facility at a 53-acre life science district in Houston.
ALS genetic carrier finds value in EverythingALS study leveraging digital biomarkers as a means to create tools for early detection of ALS and potentially other neurological diseases.
Millstone Medical Outsourcing has acquired MycoScience to add laboratory and environmental testing services to its offering.
First ever longtudinal study from ALS non-profit focuses on finding digital biomarkers using IBM Research’s proprietary AI. The study leverages audiovisual samples from participants with ALS, genetic carriers, and caregivers.